Good, Chester B.

GLP-1 receptor agonist discontinuation among patients with obesity and/or type 2 diabetes

Do, D., Lee, T., Peasah, S. K., Good, C. B., Inneh, A., & Patel, U. (2024) · JAMA Network Open

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 218

Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia

Thorpe, C. T., Gellad, W. F., Good, C. B., Zhang, S., Zhao, X., Mor, M., & Fine, M. J. (2015) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 140

Pre-Transplant Depression Is Associated with Length of Hospitalization, Discharge Disposition, and Survival after Liver Transplantation

Rogal, S. S., Mankaney, G., Udawatta, V., Chinman, M., Good, C. B., Zickmund, S., Bielefeldt, K., Chidi, A., Jonassaint, N., Jazwinski, A., et al. (2016) · PLOS ONE

Organ Transplantation Techniques and OutcomesOrgan and Tissue Transplantation Research

Cited by 43

Pharmacotherapy for weight management in the VHA

Semla, T. P., Ruser, C., Good, C. B., Yanovski, S. Z., Ames, D., Copeland, L. A., Billington, C., Ferguson, U. I., Aronne, L. J., Wadden, T. A., et al. (2017) · Journal of General Internal Medicine

Pharmacology and Obesity TreatmentObesity and Health Practices

Cited by 28

Trends in Pediatric Attention-Deficit Hyperactive Disorder Diagnoses and Prescription Utilization: 2016 to 2019

Kazarov, C., Peasah, S. K., McConnell, E., Fischer, K. K., & Good, C. B. (2024) · Journal of Developmental & Behavioral Pediatrics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 4